The Tempest, a tale of love, revenge and family set at sea, is thought to be the last play that William Shakespeare wrote alone.

One area it doesn’t touch on in detail is staggering riches; a theme now more relevant to shareholders in Tempest Minerals (ASX:TEM) after the stock roared higher by almost 300% today following a big copper hit in WA (details below).

Speaking of love, revenge and family, buckle up — because not even the most dedicated investor will be able to escape the next lead of the 24-hour news cycle; Will Smith going absolutely berserk at the 2022 Oscars.

Actions speak louder than words (although the words were also loud):

Chris Rock caught the Fresh Prince Slap, which looks to have been in response to a ‘GI Jane 2′ joke about Jada Pinkett Smith (Will’s wife) who suffers from alopecia, an autoimmune disorder that leads to hair loss.

After dishing out the slap heard ’round the world, Smith then went on to win the Best Actor gong for King Richard (not a Shakespeare play) — a film about the father of tennis superstars Venus and Serena Williams.

Back on markets, the ASX microcap Emerging Companies index got slapped around a bit too, finishing 0.56% lower after treading water in morning trade.

Looking ahead to the Wall Street open, US stocks are also pointing lower with Nasdaq futures trading at ~-0.4%.


(Stocks highlighted in yellow rose after making announcements during the trading day).

Scroll or swipe to reveal table. Click headings to sort.

Tempest started with a bang, and things got even better through the course of the session as investors re-rated the stock following a big copper discovery from the first drill-holes at Orion, part of its flagship ‘Meleya’ project in WA.

The stock closed at 2.3c on Friday following a 15% jump, before surging by almost 300% in Monday trade to close at 8.7c.

Tempest’s drill program pulled up three mineralised copper sections, including one to “end of hole” which suggests the mineralisation continues at depth.

A number of other resources stocks caught the market’s attention today with new announcements, including nanocap gold explorer Riedel Resources (ASX:RIE).

Riedel said its reverse circulation drill program remains on track at its Kingman gold project in Arizona, with first assay results due in June or “hopefully sooner, subject to laboratory turnaround”, the company said.

Elsewhere in resources (which dominated today’s winner’s list), gold explorer Octanex (ASX:OXX) surged by more than 50% on no news.

Based in WA, the company is on the hunt for large scale gold systems via three projects in the Eastern Goldfields.



(Stocks highlighted in yellow fell after making announcements during the trading day).

Scroll or swipe to reveal table. Click headings to sort.



Cazaly Resources Limited (ASX: CAZ) has announced promising analytical results for surface samples at the Yabby Prospect in the north-eastern goldfields of WA. Several N-S and NNE gold mineralised trends have been identified in first pass reconnaissance surface samples.

The initial sampling program consisted of 209 lag samples collected on a broad spaced grid 400m x 200m across the entire project. Geochemical interpretation of multi-element data is underway and infill sampling will be planned to refine geochemical anomalies to generate drill targets. (ASX:CAR) has appointed Paul Barlow as managing director of carsales Australia following the resignation of Ajay Bhatia who will take up a CEO role with a European digital marketplace firm.

Barlow has been with carsales for the past 13 years, including the last 8 years as managing director international. The chief financial officer of Will Eilliott will take on accountability for carsales’ investments which include Tyresales, Redbook Inspect and iMotor.

West Cobar Metals (ASX:WC1) has appointed Kevin Das as an executive director. Das has more than 18 years experience in mining as a senior geologist and has undertaken several technical and corporate roles.

Das is the co-founder of ARD Group where he is responsible for the fund’s investment strategy, implementation of capital allocation and daily management activities.

And Recce Pharmaceuticals (ASX:RCE,FSE:R9Q) which develops a new class of synthetic anti-infectives has received a research and development tax incentive rebate of ~$3 million from the Federal Government for FY21.

CEO James Graham said the rebate assists the company to undertake its critical work in its infectious diseases programs and further strengthens its strong financial position to deliver on short and long-term milestones.


Cycliq Group (ASX:CYQ) — Partnership agreement

Vimy Resources (ASX:VMY) — Potential transaction

Deep Yellow (ASX:DYL) — Potential control transaction

Kogi Iron (ASX:KFE) — Capital raising

Carnarvon Energy (ASX:CVN) — Capital raising

Latin Resources (ASX:LRS) — Assay results, Salinas lithium project (Brazil)